Migraine Minute News Update

Association of Migraine Disorders
  • 5,0 (4)
  • FORME ET SANTÉ
  • TOUS LES 2 MOIS
Migraine Minute News Update

The Migraine Minute provides weekly updates in migraine research and news hosted by Molly O'Brien of the Association of Migraine Disorders.

  1. -4 J

    FDA Clears Nerivio Device for Children 8+

    Kids age 8+ now have access to a non-drug migraine treatment option. In this Migraine Minute News Update, Molly O’Brien explains the FDA clearance of Theranica’s Nerivio device for acute and preventive migraine treatment in kids.   Read more: https://bit.ly/4fRXRk5

    1 min

  2. 13/12/2024

    MERTK as a Potential Novel Target for Cluster Headache

    Researchers have identified elevated levels of the gene MERTK, (which is linked to cluster headaches) and its ligand Gal-3, in the nerve tissues of rats and in blood samples of people with cluster headache. In this Migraine Minute News Update Molly O’Brien breaks down what it means for people living with Cluster. Read More: https://bit.ly/3ZXzTQ0

    1 min

  3. 15/11/2024

    No Link Between Migraine and Risk of Parkinson’s Disease

    Contrary to previous research, a study published in Neurology finds among women, there is no link between migraine and the risk of developing Parkinson’s disease. Molly O’Brien explains in this Migraine Minute News Update.   Want to know more about Migraine and Parkinson’s disease? Check out this article in AMD’s Comorbidities library: https://bit.ly/3XZSaJB

    1 min

  4. 01/11/2024

    New Treatment Targets PACAP for Migraine Prevention

    A small study published in the New England Journal of Medicine finds a single IV infusion of a Monoclonal Antibody targeting PACAP reduced monthly migraine days better than placebo. In this Migraine Minute News Update Molly O’Brien explains. Read More: https://bit.ly/3XXXNrR

    1 min

  5. 10/10/2024 · VIDÉO

    NINDS Funds Research on the Link Between Headache Disorders & the Circadian Clock

    The National Institute of Neurological Disorders and Stroke awards a $2.4 million grant to researchers at the University of Texas Health to examine the link between the circadian clock and severe headache disorders. Molly O’Brien has details in this Migraine Minute News Update. Read more: bit.ly/3BsNwfT

    1 min

  6. 20/09/2024

    Can CGRP blockers impact blood pressure in people over 60?

    A study finds treatment with anti-CGRP mAbs does not significantly affect blood pressure or increase the occurrence of hypertension (compared to general population trends) in people 60+. In this Migraine Minute, Molly O’Brien explains the findings.  Read More: bit.ly/3zpcYSB

    1 min

  7. 06/09/2024

    Are CGRP mAbs Cost Effective?

    A study found that anti-CGRP monoclonal antibodies not only reduced absenteeism & presenteeism in Spain, they were found to be cost-effective too. Read more: http://bit.ly/3S1KS5Y Image courtesy: DOI 10.1186/s10194-024-01727-0

    1 min

  8. 16/08/2024

    Atogepant vs. Rimegepant. New study looks at indirect comparison

    A new study looks at the efficacy and safety of two gepant medications. Molly O'Brien will share the study findings in this Migraine Minute News update.  Read the study: bit.ly/4cwJQar Image courtesy: Sage Journals. Cephalalgia doi:10.1177/03331024241235156

    1 min
Tout afficher (92)

Notes et avis

5
sur 5
4 notes

À propos

The Migraine Minute provides weekly updates in migraine research and news hosted by Molly O'Brien of the Association of Migraine Disorders.

Informations

  • Création
    Association of Migraine Disorders
  • Années d’activité
    2021 - 2025
  • Épisodes
    92
  • Classification
    Tous publics
  • Site web de l’émission
    Migraine Minute News Update

Vous aimeriez peut‑être aussi

Pour écouter des épisodes au contenu explicite, connectez‑vous.

Recevez les dernières actualités sur cette émission

Connectez‑vous ou inscrivez‑vous pour suivre des émissions, enregistrer des épisodes et recevoir les dernières actualités.
Choisissez un pays ou une région

Afrique, Moyen‑Orient et Inde

Asie‑Pacifique

Europe

Amérique latine et Caraïbes

États‑Unis et Canada